Tiny RNA molecules carried by extracellular vesicles in the bloodstream can accurately predict kidney function decline and cardiovascular risk in chronic kidney disease (CKD), as reported by ...

Chronic kidney disease (CKD) is complex with diverse causes yet genetic studies often rely on only one or two biomarkers to investigate it. Novel approach to studying underlying genetic causes of CKD ...

Many older individuals receive a false diagnosis of CKD stage 3, two nephrologists say. Two nephrologists believe CKD is being overdiagnosed in the United States, particularly among the elderly. The ...

Jonathan Himmelfarb, MD As the nephrology community grapples with a wide range of issues, Renal & Urology News (RUN) turned to Jonathan Himmelfarb, MD, Chair of the Public Policy Board at the American ...

Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and cardiovascular ...

Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...